The use of tail-anchored protein chimeras to enhance liposomal cargo delivery.

<h4>Background</h4>Liposomes are employed as drug delivery vehicles offering a beneficial pharmacokinetic/distribution mechanism for in vivo therapeutics. Therapeutic liposomes can be designed to target specific cell types through the display of epitope-specific targeting peptides on the...

Full description

Bibliographic Details
Main Authors: Abbi Abdelrehim, Lior Shaltiel, Ling Zhang, Yechezkel Barenholz, Stephen High, Lynda K Harris
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2019-01-01
Series:PLoS ONE
Online Access:https://doi.org/10.1371/journal.pone.0212701
_version_ 1819033278459412480
author Abbi Abdelrehim
Lior Shaltiel
Ling Zhang
Yechezkel Barenholz
Stephen High
Lynda K Harris
author_facet Abbi Abdelrehim
Lior Shaltiel
Ling Zhang
Yechezkel Barenholz
Stephen High
Lynda K Harris
author_sort Abbi Abdelrehim
collection DOAJ
description <h4>Background</h4>Liposomes are employed as drug delivery vehicles offering a beneficial pharmacokinetic/distribution mechanism for in vivo therapeutics. Therapeutic liposomes can be designed to target specific cell types through the display of epitope-specific targeting peptides on their surface. The majority of peptides are currently attached by chemical modification of lipid constituents. Here we investigate an alternative and novel method of decorating liposomes with targeting ligand, using remotely and spontaneously inserting chimeric tail-anchored membrane (TA) proteins to drug loaded liposomes.<h4>Methods and results</h4>An artificial TA protein chimera containing the transmembrane domain from the spontaneously inserting TA protein cytochrome b5 (Cytb5) provided a robust membrane tether for the incorporation of three different targeting moieties into preformed liposomes. The moieties investigated were the transactivator of transcription (TAT) peptide, the EGF-receptor binding sequence GE11 and the placental and tumour homing ligand CCGKRK. In all cases, TA protein insertion neither significantly altered the size of the liposomes nor reduced drug loading. The efficacy of this novel targeted delivery system was investigated using two human cell lines, HeLa M and BeWo. Short term incubation with one ligand-modified TA chimera, incorporating the TAT peptide, significantly enhanced liposomal delivery of the encapsulated carboxyfluorescein reporter.<h4>Conclusion</h4>The Cytb5 TA was successfully employed as a membrane anchor for the incorporation of the desired peptide ligands into a liposomal drug delivery system, with minimal loss of cargo during insertion. This approach therefore provides a viable alternative to chemical conjugation and its potential to accommodate a wider range of targeting ligands may provide an opportunity for enhancing drug delivery.
first_indexed 2024-12-21T07:15:18Z
format Article
id doaj.art-653a1e5b611c45cc8038512087df389f
institution Directory Open Access Journal
issn 1932-6203
language English
last_indexed 2024-12-21T07:15:18Z
publishDate 2019-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj.art-653a1e5b611c45cc8038512087df389f2022-12-21T19:11:53ZengPublic Library of Science (PLoS)PLoS ONE1932-62032019-01-01142e021270110.1371/journal.pone.0212701The use of tail-anchored protein chimeras to enhance liposomal cargo delivery.Abbi AbdelrehimLior ShaltielLing ZhangYechezkel BarenholzStephen HighLynda K Harris<h4>Background</h4>Liposomes are employed as drug delivery vehicles offering a beneficial pharmacokinetic/distribution mechanism for in vivo therapeutics. Therapeutic liposomes can be designed to target specific cell types through the display of epitope-specific targeting peptides on their surface. The majority of peptides are currently attached by chemical modification of lipid constituents. Here we investigate an alternative and novel method of decorating liposomes with targeting ligand, using remotely and spontaneously inserting chimeric tail-anchored membrane (TA) proteins to drug loaded liposomes.<h4>Methods and results</h4>An artificial TA protein chimera containing the transmembrane domain from the spontaneously inserting TA protein cytochrome b5 (Cytb5) provided a robust membrane tether for the incorporation of three different targeting moieties into preformed liposomes. The moieties investigated were the transactivator of transcription (TAT) peptide, the EGF-receptor binding sequence GE11 and the placental and tumour homing ligand CCGKRK. In all cases, TA protein insertion neither significantly altered the size of the liposomes nor reduced drug loading. The efficacy of this novel targeted delivery system was investigated using two human cell lines, HeLa M and BeWo. Short term incubation with one ligand-modified TA chimera, incorporating the TAT peptide, significantly enhanced liposomal delivery of the encapsulated carboxyfluorescein reporter.<h4>Conclusion</h4>The Cytb5 TA was successfully employed as a membrane anchor for the incorporation of the desired peptide ligands into a liposomal drug delivery system, with minimal loss of cargo during insertion. This approach therefore provides a viable alternative to chemical conjugation and its potential to accommodate a wider range of targeting ligands may provide an opportunity for enhancing drug delivery.https://doi.org/10.1371/journal.pone.0212701
spellingShingle Abbi Abdelrehim
Lior Shaltiel
Ling Zhang
Yechezkel Barenholz
Stephen High
Lynda K Harris
The use of tail-anchored protein chimeras to enhance liposomal cargo delivery.
PLoS ONE
title The use of tail-anchored protein chimeras to enhance liposomal cargo delivery.
title_full The use of tail-anchored protein chimeras to enhance liposomal cargo delivery.
title_fullStr The use of tail-anchored protein chimeras to enhance liposomal cargo delivery.
title_full_unstemmed The use of tail-anchored protein chimeras to enhance liposomal cargo delivery.
title_short The use of tail-anchored protein chimeras to enhance liposomal cargo delivery.
title_sort use of tail anchored protein chimeras to enhance liposomal cargo delivery
url https://doi.org/10.1371/journal.pone.0212701
work_keys_str_mv AT abbiabdelrehim theuseoftailanchoredproteinchimerastoenhanceliposomalcargodelivery
AT liorshaltiel theuseoftailanchoredproteinchimerastoenhanceliposomalcargodelivery
AT lingzhang theuseoftailanchoredproteinchimerastoenhanceliposomalcargodelivery
AT yechezkelbarenholz theuseoftailanchoredproteinchimerastoenhanceliposomalcargodelivery
AT stephenhigh theuseoftailanchoredproteinchimerastoenhanceliposomalcargodelivery
AT lyndakharris theuseoftailanchoredproteinchimerastoenhanceliposomalcargodelivery
AT abbiabdelrehim useoftailanchoredproteinchimerastoenhanceliposomalcargodelivery
AT liorshaltiel useoftailanchoredproteinchimerastoenhanceliposomalcargodelivery
AT lingzhang useoftailanchoredproteinchimerastoenhanceliposomalcargodelivery
AT yechezkelbarenholz useoftailanchoredproteinchimerastoenhanceliposomalcargodelivery
AT stephenhigh useoftailanchoredproteinchimerastoenhanceliposomalcargodelivery
AT lyndakharris useoftailanchoredproteinchimerastoenhanceliposomalcargodelivery